相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of prolonged subchronic benzo(α)pyrene exposure on rat liver morphology and CYP1A expression during treatment with menadione, quercetin, or tocopherol
M. L. Perepechaeva et al.
DRUG AND CHEMICAL TOXICOLOGY (2022)
CYP1A2rs762551 polymorphism and risk for amyotrophic lateral sclerosis
Vasileios Siokas et al.
NEUROLOGICAL SCIENCES (2021)
Downregulation of CYP1A2, CYP2B6, and CYP3A4 in Human Hepatocytes by Prolyl Hydroxylase Domain 2 Inhibitors via Hypoxia-Inducible Factor-α Stabilization
Hiroki Takano et al.
DRUG METABOLISM AND DISPOSITION (2021)
Cytochrome P450 1A2 overcomes nuclear factor kappa B-mediated sorafenib resistance in hepatocellular carcinoma
Jianqing Yu et al.
ONCOGENE (2021)
Design, synthesis, and enzymatic characterization of quinazoline-based CYP1A2 inhibitors
Pedro A. Corral et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Functional cytochrome P450 1A enzymes are induced in mouse and human islets following pollutant exposure
Muna Ibrahim et al.
DIABETOLOGIA (2020)
Evaluation of the time-dependent antiproliferative activity and liver microsome stability of 3 phenyl 4-(2-oxo-3-alkylimidazolidin-1-yl)benzenesulfonates as promising CYP1A1-dependent antimicrotubule prodrugs
Mitra Zarifi Khosroshahi et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2020)
Inhibition of CYP1B1 ameliorates cardiac hypertrophy induced by uremic toxin
Ying Zhang et al.
MOLECULAR MEDICINE REPORTS (2020)
Impact of CYP1A2, CYP2C19, and CYP2D6 genotype- and phenoconversion-predicted enzyme activity on clozapine exposure and symptom severity
Dorothea Lesche et al.
PHARMACOGENOMICS JOURNAL (2020)
Polymorphisms and endometriosis: a systematic review and meta-analyses
Loren Mear et al.
HUMAN REPRODUCTION UPDATE (2020)
CYP1A1 gene (6235T<C) polymorphism as a risk factor for polycystic ovarian syndrome among Egyptian women
Nervana Bayoumy et al.
HUMAN FERTILITY (2020)
Human CYP1A1 inhibition by flavonoids
Rebeca Santes-Palacios et al.
TOXICOLOGY IN VITRO (2020)
New insights of CYP1A in endogenous metabolism: a focus on single nucleotide polymorphisms and diseases
Jian Lu et al.
ACTA PHARMACEUTICA SINICA B (2020)
Cytochrome P450 1A1 enhances inflammatory responses and impedes phagocytosis of bacteria in macrophages during sepsis
Li-Xing Tian et al.
CELL COMMUNICATION AND SIGNALING (2020)
Carvedilol serves as a novel CYP1B1 inhibitor, a systematic drug repurposing approach through structure-based virtual screening and experimental verification
Ying Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
6β-Hydroxytestosterone, a metabolite of testosterone generated by CYP1B1, contributes to vascular changes in angiotensin II-induced hypertension in male mice
Ajeeth K. Pingili et al.
BIOLOGY OF SEX DIFFERENCES (2020)
Retinal astrocytes transcriptome reveals Cyp1b1 regulates the expression of genes involved in cell adhesion and migration
Juliana Falero-Perez et al.
PLOS ONE (2020)
CYP1A2 rs762551 and ADORA2A rs5760423 Polymorphisms in Patients with Blepharospasm
Vasileios Siokas et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2020)
Is there a future for CYP1A2 pharmacogenetics in the optimal dosing of clozapine?
Can-Jun Ruan et al.
PHARMACOGENOMICS (2020)
CYP1A1andGSTs common gene variations and presbycusis risk: a genetic association analysis and a bioinformatics approach
Mohammad Karimian et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2020)
Bisphenol A regulates cytochrome P450 1B1 through miR-27b-3p and induces carp lymphocyte oxidative stress leading to apoptosis
Qingqing Liu et al.
FISH & SHELLFISH IMMUNOLOGY (2020)
A meta-analysis andin silicoanalysis of polymorphic variants conferring breast cancer risk in the Indian subcontinent
Debmalya Sengupta et al.
FUTURE ONCOLOGY (2020)
How the AHR Became Important in Intestinal Homeostasis-A Diurnal FICZ/AHR/CYP1A1 Feedback Controls Both Immunity and Immunopathology
Agneta Rannug
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Polycyclic Aromatic Hydrocarbon-induced Pulmonary Carcinogenesis in Cytochrome P450 (CYP)1A1-and 1A2-Null Mice: Roles of CYP1A1 and CYP1A2
Grady Gastelum et al.
TOXICOLOGICAL SCIENCES (2020)
Brain Testosterone-CYP1B1 (Cytochrome P450 1B1) Generated Metabolite 6 beta-Hydroxytestosterone Promotes Neurogenic Hypertension and Inflammation
Purnima Singh et al.
HYPERTENSION (2020)
The influence ofCYP1A1andCYP1A2polymorphisms on stroke risk in the Chinese population
Yan Mao et al.
LIPIDS IN HEALTH AND DISEASE (2020)
Knockout of cytochrome P450 1A1 enhances lipopolysaccharide-induced acute lung injury in mice by targeting NF-κB activation
Li-xing Tian et al.
FEBS OPEN BIO (2020)
Regulation of High-Altitude Hypoxia on the Transcription of CYP450 and UGT1A1 Mediated by PXR and CAR
Ya-bin Duan et al.
FRONTIERS IN PHARMACOLOGY (2020)
Genotype of Null Polymorphisms in Genes GSTM1, GSTT1, CYP1A1, and CYP1A1*2A (rs4646903 T>C)/CYP1A1*2C (rs1048943 A>G) in Patients with Larynx Cancer in Southeast Spain
Mariano Sanchez-Siles et al.
CANCERS (2020)
Polymorphisms and haplotypes of TLR4, TLR9 and CYP1A1 genes possibly interfere with high-risk human papillomavirus infection and cervical cancer susceptibility in Jharkhand, India
Nidhi Nath et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Association of cytochrome P450 1B1 gene polymorphisms and environmental biomarkers with hypertension in Slovak midlife women
Darina Falbova et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2020)
CYP1B1 gene: Implications in glaucoma and cancer
Arwa Alsubait et al.
JOURNAL OF CANCER (2020)
Hyaluronic acid-modified cationic nanoparticles overcome enzyme CYP1B1-mediated breast cancer multidrug resistance
Jun Zhang et al.
NANOMEDICINE (2019)
Functional expression and activity screening of all human cytochrome P450 enzymes in fission yeast
Pradeepraj Durairaj et al.
FEBS LETTERS (2019)
Association of CYP1A1 rs1048943 variant with aggressive periodontitis and its interaction with hyperlipidemia on the periodontal status
Xian'e Wang et al.
JOURNAL OF PERIODONTAL RESEARCH (2019)
AhR regulates the expression of human cytochrome P450 1A1 (CYP1A1) by recruiting Sp1
Wenchu Ye et al.
FEBS JOURNAL (2019)
Liposome mediated-CYP1A1 gene silencing nanomedicine prepared using lipid film-coated proliposomes as a potential treatment strategy of lung cancer
Mengtian Zhang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Role of cytochrome P450 polymorphisms and functions in development of ulcerative colitis
Alaattin Sen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Left Ventricular Hypertrophy: Roles of Mitochondria CYP1B1 and Melatonergic Pathways in Co-Ordinating Wider Pathophysiology
George Anderson et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Ligand-based Pharmacophore Modeling and Virtual Screening to Discover Novel CYP1A1 Inhibitors
Rana Adnan Tahir et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2019)
Mutational analysis of the CYP1B1 gene in Pakistani primary congenital glaucoma patients: Identification of four known and a novel causative variant at the 3′ splice acceptor site of intron 2
Rabia Afzal et al.
CONGENITAL ANOMALIES (2019)
CYP1B1 prevents proteasome-mediated XIAP degradation by inducing PKCε activation and phosphorylation of XIAP
Hyoung-Seok Baek et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2019)
CYP1B1 Gene and Phenotypic Correlation in Patients From Northeastern Brazil With Primary Congenital Glaucoma
Rodrigo E. A. Coelho et al.
JOURNAL OF GLAUCOMA (2019)
Ambient fine particulate matter (PM2.5) induces oxidative stress and pro-inflammatory response via up-regulating the expression of CYP1A1/1B1 in human bronchial epithelial cells in vitro
Qi Yuan et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2019)
Hepatic CYP1A2 activity in liver tumors and the implications for preoperative volume-function analysis
Tilo Wuensch et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2019)
Emerging roles of metabolites of ω3 and ω6 essential fatty acids in the control of intestinal inflammation
Takahiro Nagatake et al.
INTERNATIONAL IMMUNOLOGY (2019)
Novel CYP1B1 mutations and a possible prognostic use for surgical management of congenital glaucoma
Mohamed M. Khafagy et al.
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY (2019)
The impact of genetic polymorphisms on CYP1A2 activity in humans: a systematic review and meta-analysis
Nut Koonrungsesomboon et al.
PHARMACOGENOMICS JOURNAL (2018)
Human Enzymes for Organic Synthesis
Margit Winkler et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Cancer chemoprevention revisited: Cytochrome P450 family 1B1 as a target in the tumor and the microenvironment
Gabriele D'Uva et al.
CANCER TREATMENT REVIEWS (2018)
Upregulation of microRNA-320 decreases the risk of developing steroid-induced avascular necrosis of femoral head by inhibiting CYP1A2 both in vivo and in vitro
Ji-Hua Wei et al.
GENE (2018)
Cytochrome P450 1B1 promotes cancer cell survival via specificity protein 1 (Sp1)-mediated suppression of death receptor 4
Yeo-Jung Kwon et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2018)
CYP1A1 Relieves Lipopolysaccharide-Induced Inflammatory Responses in Bovine Mammary Epithelial Cells
Wen-Yao Zhang et al.
MEDIATORS OF INFLAMMATION (2018)
Cytochrome P450 1A1 gene polymorphisms and cervical cancer risk: A systematic review and meta-analysis
Bo Ding et al.
MEDICINE (2018)
Caffeine, CYP1A2 Genotype, and Endurance Performance in Athletes
Nanci Guest et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2018)
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Daniel E. Johnson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Modulation of CYP1A1 metabolism: From adverse health effects to chemoprevention and therapeutic options
Melina Mescher et al.
PHARMACOLOGY & THERAPEUTICS (2018)
The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo
Dmitrij A. Sychev et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
A single nucleotide polymorphism in CYP1B1 leads to differential prostate cancer risk and telomere length
Cheng-Yuan Gu et al.
JOURNAL OF CANCER (2018)
Decreased expression of hepatic cytochrome P450 1A2 (CYP1A2) in a chronic intermittent hypoxia mouse model
Xiao-Bin Zhang et al.
JOURNAL OF THORACIC DISEASE (2018)
Mechanisms of Cytochrome P450-Catalyzed Oxidations
F. Peter Guengerich
ACS CATALYSIS (2018)
Association of Cytochrome CYP1A1 Gene Polymorphisms and Tobacco Smoking With the Risk of Breast Cancer in Women From Iraq
Hassan M. Naif et al.
FRONTIERS IN PUBLIC HEALTH (2018)
CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner
Songping Xie et al.
ONCOLOGY REPORTS (2017)
Inhibitors of cytochrome P450 (CYP) 1B1
Raphael Dutour et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines
Neill J. Horley et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Quinazoline derivatives as selective CYP1B1 inhibitors
Mohd Usman Mohd Siddique et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Activation of Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonates Prodrugs by CYP1A1 as New Antimitotics Targeting Breast Cancer Cells
Sebastien Fortin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Mitochondrial activity and oxidative stress functions are influenced by the activation of AhR-induced CYP1A1 overexpression in cardiomyocytes
Bing Zhou et al.
MOLECULAR MEDICINE REPORTS (2017)
Berberine Activates Aryl Hydrocarbon Receptor but Suppresses CYP1A1 Induction through miR-21-3p Stimulation in MCF-7 Breast Cancer Cells
Sheng-Nan Lo et al.
MOLECULES (2017)
Potential role of CYP1B1 in the development and treatment of metabolic diseases
Fei Li et al.
PHARMACOLOGY & THERAPEUTICS (2017)
PXR mediated induction of CYP3A4, CYP1A2, and P-gp by Mitragyna speciosa and its alkaloids
Vamshi K. Manda et al.
PHYTOTHERAPY RESEARCH (2017)
Newborn Mice Lacking the Gene for Cyp1a1 Are More Susceptible to Oxygen-Mediated Lung Injury, and Are Rescued by Postnatal β-Naphthoflavone Administration: Implications for Bronchopulmonary Dysplasia in Premature Infants
Paramahamsa Maturu et al.
TOXICOLOGICAL SCIENCES (2017)
MicroRNA regulation of CYP 1A2, CYP3A4 and CYP2E1 expression in acetaminophen toxicity
Pritmohinder Gill et al.
SCIENTIFIC REPORTS (2017)
Modification of the response of olfactory receptors to acetophenone by CYP1a2
Masashi Asakawa et al.
SCIENTIFIC REPORTS (2017)
Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters
Enoch Cobbina et al.
DRUG METABOLISM REVIEWS (2017)
The expression, induction and pharmacological activity of CYP1A2 are post-transcriptionally regulated by microRNA hsa-miR-132-5p
Yinting Chen et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Analysis of CYP1B1 Gene Mutations in Patients with Primary Congenital Glaucoma
Leila Chouiter et al.
JOURNAL OF PEDIATRIC GENETICS (2017)
Genetic polymorphisms of human cytochrome P450 CYP1A1 in an Egyptian population and tobacco-induced lung cancer
Nada Ezzeldin et al.
GENES AND ENVIRONMENT (2017)
MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1
Ming Mao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children
David E. Kleiner et al.
CLINICS IN LIVER DISEASE (2016)
CYP1A1 mediates the suppression of major inflammatory cytokines in pulmonary alveolar macrophage (PAM) cell lines caused by Mycoplasma hyponeumoniae
Xiaomin Fang et al.
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY (2016)
Association of oxidative stress gene polymorphisms with presbycusis
Santoshi Kumari Manche et al.
GENE (2016)
The cytochrome P4501A1 gene polymorphisms and endometriosis: a meta-analysis
Wei Fan et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2016)
CYP1B1 and MYOC Mutations in Vietnamese Primary Congenital Glaucoma Patients
Tan Do et al.
JOURNAL OF GLAUCOMA (2016)
Assessment of CYP1A2 enzyme activity in relation to type-2 diabetes and habitual caffeine intake
Emily Urry et al.
NUTRITION & METABOLISM (2016)
Regulation of Human Cytochrome P4501A1 (hCYP1A1): A Plausible Target for Chemoprevention?
Rebeca Santes-Palacios et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Carcinogenic polycyclic aromatic hydrocarbons induce CYP1A1 in human cells via a p53-dependent mechanism
Laura E. Wohak et al.
ARCHIVES OF TOXICOLOGY (2016)
CYP1B1 Enhances Cell Proliferation and Metastasis through Induction of EMT and Activation of Wnt/β-Catenin Signaling via Sp1 Upregulation
Yeo-Jung Kwon et al.
PLOS ONE (2016)
Cytochrome P450 1A2 Metabolizes 17β-Estradiol to Suppress Hepatocellular Carcinoma
Jianwai Ren et al.
PLOS ONE (2016)
Cytochrome P450 1B1: An unexpected modulator of liver fatty acid homeostasis
Michele Campaigne Larsen et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2015)
miR-27b synergizes with anticancer drugs via p53 activation and CYP1B1 suppression
Wenjing Mu et al.
CELL RESEARCH (2015)
Age-Related Changes in MicroRNA Expression and Pharmacogenes in Human Liver
K. S. Burgess et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Role of Metabolic Enzymes P450 (CYP) on Activating Procarcinogen and their Polymorphisms on the Risk of Cancers
Xin He et al.
CURRENT DRUG METABOLISM (2015)
Association of coffee consumption and CYP1A2 polymorphism with risk of impaired fasting glucose in hypertensive patients
Paolo Palatini et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2015)
Design and Synthesis of New α-Naphthoflavones as Cytochrome P450 (CYP) 1B1 Inhibitors To Overcome Docetaxel-Resistance Associated with CYP1B1 Overexpression
Jiahua Cui et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Polycyclic Aromatic Hydrocarbons: From Metabolism to Lung Cancer
Bhagavatula Moorthy et al.
TOXICOLOGICAL SCIENCES (2015)
Mutation spectrum of CYP1B1 in Chinese patients with primary open-angle glaucoma
Bo Gong et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2015)
Survey of Human Oxidoreductases and Cytochrome P450 Enzymes Involved in the Metabolism of Xenobiotic and Natural Chemicals
Slobodan Rendic et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2015)
Interleukin-6 mediated upregulation of CYP1B1 and CYP2E1 in colorectal cancer involves DNA methylation, miR27b and STAT3
S. A. A. Patel et al.
BRITISH JOURNAL OF CANCER (2014)
Beneficial effects of soluble dietary Jerusalem artichoke (Helianthus tuberosus) in the prevention of the onset of type 2 diabetes and non-alcoholic fatty liver disease in high-fructose diet-fed rats
Wan-Ching Chang et al.
BRITISH JOURNAL OF NUTRITION (2014)
CYP1A1 and CYP1B1-Mediated Biotransformation of the Antitrypanosomal Methamidoxime Prodrug DB844 Forms Novel Metabolites Through Intramolecular Rearrangement
Wujian Ju et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Induction of CYP1A1, CYP1A2, CYP1B1, increased oxidative stress and inflammation in the lung and liver tissues of rats exposed to incense smoke
Tajamul Hussain et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
A Novel Methodology for Enhanced and Consistent Heterologous Expression of Unmodified Human Cytochrome P450 1B1 (CYP1B1)
Muneeb A. Faiq et al.
PLOS ONE (2014)
Arsenic exposure triggers a shift in microRNA expression
Elena Sturchio et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2014)
Mice Deficient in the Gene for Cytochrome P450 (CYP)1A1 Are More Susceptible Than Wild-Type to Hyperoxic Lung Injury: Evidence for Protective Role of CYP1A1 Against Oxidative Stress
Krithika Lingappan et al.
TOXICOLOGICAL SCIENCES (2014)
Genetic variation in the 3′-UTR of CYP1A2, CYP2B6, CYP2D6, CYP3A4, NR1I2, and UGT2B7: potential effects on regulation by microRNA and pharmacogenomics relevance
Marelize Swart et al.
FRONTIERS IN GENETICS (2014)
Theophylline
Peter J. Barnes
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Considering CYP1A2 phenotype and genotype for optimizing the dose of olanzapine in the management of schizophrenia
Vidya Perera et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)
Cytochrome P450-activated prodrugs
Paul R Ortiz de Montellano
Future Medicinal Chemistry (2013)
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Bone Marrow Injury Induced via Oxidative Stress in Mice by Inhalation Exposure to Formaldehyde
Yuchao Zhang et al.
PLOS ONE (2013)
CYP1B1 Polymorphisms and Susceptibility to Prostate Cancer: A Meta-Analysis
Hongtuan Zhang et al.
PLOS ONE (2013)
Human cytochromes P450 in health and disease
Daniel W. Nebert et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2013)
Expression Variability of Absorption, Distribution, Metabolism, Excretion-Related MicroRNAs in Human Liver: Influence of Nongenetic Factors and Association with Gene Expressions
Jessica K. Rieger et al.
DRUG METABOLISM AND DISPOSITION (2013)
Specificity Determinants of CYP1B1 Estradiol Hydroxylation
Clinton R. Nishida et al.
MOLECULAR PHARMACOLOGY (2013)
Cytochrome P450 1B1 Gene Disruption Minimizes Deoxycorticosterone Acetate-Salt-Induced Hypertension and Associated Cardiac Dysfunction and Renal Damage in Mice
Brett L. Jennings et al.
HYPERTENSION (2012)
CYP1A1 is a target of miR-892a-mediated post-transcriptional repression
Yeong Min Choi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Association between CYP1A1 polymorphism and colorectal cancer risk: a meta-analysis
Yuan Zheng et al.
MOLECULAR BIOLOGY REPORTS (2012)
Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM
N. Amin et al.
MOLECULAR PSYCHIATRY (2012)
Molecular Basis for Involvement of CYP1B1 in MYOC Upregulation and Its Potential Implication in Glaucoma Pathogenesis
Suddhasil Mookherjee et al.
PLOS ONE (2012)
Modification of the duocarmycin pharmacophore enables CYP1A1 targeting for biological activity
Klaus Pors et al.
CHEMICAL COMMUNICATIONS (2011)
Drug metabolism alterations in nonalcoholic fatty liver disease
Matthew D. Merrell et al.
DRUG METABOLISM REVIEWS (2011)
CYP2S1 and CYP2W1 Mediate 2-(3,4-Dimethoxyphenyl)-5-Fluorobenzothiazole (GW-610, NSC 721648) Sensitivity in Breast and Colorectal Cancer Cells
Boon Shing Tan et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Application of Homology Modeling to Generate CYP1A1 Mutants with Enhanced Activation of the Cancer Chemotherapeutic Prodrug Dacarbazine
Benjamin C. Lewis et al.
MOLECULAR PHARMACOLOGY (2011)
Constitutive androstane receptor transcriptionally activates human CYP1A1 and CYP1A2 genes through a common regulatory element in the 5′-flanking region
Kouichi Yoshinari et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Functional analysis of CYP1B1 mutations and association of heterozygous hypomorphic alleles with primary open-angle glaucoma
M-P Lopez-Garrido et al.
CLINICAL GENETICS (2010)
Species-Specific Differential AhR Expression Protects Human Neural Progenitor Cells against Developmental Neurotoxicity of PAHs
Kathrin Gassmann et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2010)
Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2-163C>A polymorphism
Natasa Djordjevic et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Angiotensin II-Induced Vascular Smooth Muscle Cell Migration and Growth Are Mediated by Cytochrome P450 1B1-Dependent Superoxide Generation
Fariborz A. Yaghini et al.
HYPERTENSION (2010)
Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases
Beshay N. M. Zordoky et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Pathway-targeted pharmacogenornics of CYP1A2 in human liver
Kathrin Klein et al.
FRONTIERS IN PHARMACOLOGY (2010)
Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention
Vasilis P. Androutsopoulos et al.
BMC CANCER (2009)
CYP1A1/2 Haplotypes and Lung Cancer and Assessment of Confounding by Population Stratification
Melinda C. Aldrich et al.
CANCER RESEARCH (2009)
Functional Analysis of GC Box and its CpG Methylation in the Regulation of CYP1A2 Gene Expression
Atsushi Miyajima et al.
DRUG METABOLISM AND PHARMACOKINETICS (2009)
CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension
Paolo Palatini et al.
JOURNAL OF HYPERTENSION (2009)
Comprehensive characterization of cytochrome P450 isozyme selectivity across chemical libraries
Henrike Veith et al.
NATURE BIOTECHNOLOGY (2009)
Allele-specific expression and gene methylation in the control of CYP1A2 mRNA level in human livers
Roza Ghotbi et al.
PHARMACOGENOMICS JOURNAL (2009)
Potent inhibition of human cytochrome P450 1B1 by tetramethoxystilbene
Young-Jin Chun et al.
TOXICOLOGY LETTERS (2009)
Hepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease
Craig D. Fisher et al.
DRUG METABOLISM AND DISPOSITION (2009)
Role of CYP1B1 in glaucoma
Vasills Vasiliou et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
CYP2B6: New insights into a historically overlooked cytochrome P450 isozyme
Hongbing Wang et al.
CURRENT DRUG METABOLISM (2008)
Heme-iron oxygenases: powerful industrial biocatalysts?
Mattijs K. Julsing et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2008)
Mutations in CYP1B1 cause primary congenital glaucoma by reduction of either activity or abundance of the enzyme
Gabriela Chavarria-Soley et al.
HUMAN MUTATION (2008)
Association of the CYP1B1*3 allele with survival in patients with prostate cancer receiving docetaxel
Tristan M. Sissung et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms
Arzu Gunes et al.
PHARMACOGENOMICS (2008)
Diagnosis of Nonalcoholic Fatty Liver Disease: Invasive versus Noninvasive
Anna Wieckowska et al.
SEMINARS IN LIVER DISEASE (2008)
Aminoflavone induces oxidative DNA damage and reactive oxidative species-mediated apoptosis in breast cancer cells
Lancelot McLean et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Induction of CYP1A2 by heavy coffee consumption in Serbs and Swedes
Natasa Djordjevic et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Effects of gender and moderate smoking on the pharmacokinetics and effects of the CYP1A2 substrate tizanidine
Janne T. Backman et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Glaucoma-associated CYP1B1 mutations share similar haplotype backgrounds in POAG and PACG phenotypes
Subhabrata Chakrabarti et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Cytochrome P4501B1-mediated estrogen metabolism results in estrogen-deoxyribonucleoside adduct formation
Alexandra R. Belous et al.
CANCER RESEARCH (2007)
The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis
Daniel W. Nebert et al.
NATURE REVIEWS CANCER (2006)
Disease-causing mutations in proteins: Structural analysis of the CYP1b1 mutations causing primary congenital glaucoma in humans
Malkaram S. Achary et al.
BIOPHYSICAL JOURNAL (2006)
Effects of the potential chemopreventive agent DMU-135 on adenoma development in the ApcMin+ mouse
S. Sale et al.
INVESTIGATIONAL NEW DRUGS (2006)
MicroRNA regulates the expression of human cytochrome P4501B1
Yuki Tsuchiya et al.
CANCER RESEARCH (2006)
CYP1A1 activation of aminoflavone leads to DNA damage in human tumor cell lines
LJ Pobst et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Coffee, CYP1A2 genotype, and risk of myocardial infarction
MC Cornelis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Cytochrome P450 pharmacogenetics and cancer
C Rodriguez-Antona et al.
ONCOGENE (2006)
Gene mapping for primary open angle glaucoma
BJ Fan et al.
CLINICAL BIOCHEMISTRY (2006)
Melatonin receptors in chick ocular tissues: Implications for a role of melatonin in ocular growth regulation
JAS Rada et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
Immunolocalization of CYP1B1 in normal, human, fetal and adult eyes
M Doshi et al.
EXPERIMENTAL EYE RESEARCH (2006)
Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer
T Tokizane et al.
CLINICAL CANCER RESEARCH (2005)
Structure and chemistry of cytochrome P450
IG Denisov et al.
CHEMICAL REVIEWS (2005)
Proteasomal degradation of human CYP1B1: Effect of the Asn453Ser polymorphism on the post-translational regulation of CYP1B1 expression
S Bandiera et al.
MOLECULAR PHARMACOLOGY (2005)
Assessment of CYP1A2 activity in clinical practice: Why, how, and when?
MS Faber et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2005)
The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate
TD Bradshaw et al.
CURRENT MEDICINAL CHEMISTRY (2004)
Fluvoxamine drastically increases concentrations and effects of tizanidine: A potentially hazardous interaction
MT Granfors et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Down-regulation od hepatic CYP1A2 plays an important role in inflammatory responses in sepsis
JH Crawford et al.
CRITICAL CARE MEDICINE (2004)
Genetic polymorphism of CYP1A2 increases the risk of myocardial infarction
MC Cornelis et al.
JOURNAL OF MEDICAL GENETICS (2004)
In vitro model of mammary estrogen metabolism: Structural and kinetic differences between catechol estrogens 2-and 4-hydroxyestradiol
S Dawling et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2004)
Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P4501B1
D Choudhary et al.
DRUG METABOLISM AND DISPOSITION (2004)
Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH
Y Yoshioka et al.
JOURNAL OF GASTROENTEROLOGY (2004)
Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: Effects of liver function
R Orlando et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Six novel nonsynonymous CYP1A2 gene polymorphisms: Catalytic activities of the naturally occurring variant enzymes
N Murayama et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer
DW Nebert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
CYP1A1, cigarette smoking, and colon and rectal cancer
ML Slattery et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Regulation of CYP1A2 by histone deacetylase inhibitors in mouse hepatocytes
B Jin et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2004)
Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants
DR Nelson et al.
PHARMACOGENETICS (2004)
Cytochrome P450 1A2 (CYP1A2) activity, mammographic density, and oxidative stress: a cross-sectional study
CC Hong et al.
BREAST CANCER RESEARCH (2004)
Discovery of cytochrome p450 1B1 inhibitors as new promising anti-cancer agents
YJ Chun et al.
MEDICINAL RESEARCH REVIEWS (2003)
Polymorphisms in the CYP1B1 gene are associated with increased risk of prostate cancer
BL Chang et al.
BRITISH JOURNAL OF CANCER (2003)
Modification of ocular defects in mouse developmental glaucoma models by tyrosinase
RT Libby et al.
SCIENCE (2003)
2-methoxyestradiol, a promising anticancer agent
NJ Lakhani et al.
PHARMACOTHERAPY (2003)
Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism
C Sachse et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Activation of the antitumor agent aminoflavone (NSC 686288) is mediated by induction of tumor cell cytochrome P450 1A1/1A2
MJ Kuffel et al.
MOLECULAR PHARMACOLOGY (2002)
Anterior segment dysgenesis and the developmental glaucomas are complex traits
DB Gould et al.
HUMAN MOLECULAR GENETICS (2002)
Microsomal cytochrome P450 and eicosanoid metabolism
JH Capdevila et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2002)
Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine
DF Zullino et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2002)
The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYPIBI
GA Potter et al.
BRITISH JOURNAL OF CANCER (2002)
Digenic inheritance of early-onset glaucoma:: CYP1B1, a potential modifier gene
AL Vincent et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Caffeine test in predicting flutamide-induced hepatic injury in patients with prostate cancer
S Ozono et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2002)
Role of human cytochrome P450 1A1, IA2, 1B1, and 3A4 in the 2-, 4-, and 16α-hydroxylation of 17β-estradiol
AF Badawi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2001)
Regulation, function, and tissue-specific expression of cytochrome P450CYP1B1
GI Murray et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Molecular genetics of primary congenital glaucoma
M Sarfarazi et al.
EYE (2000)
Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer
J Watanabe et al.
PHARMACOGENETICS (2000)
Androgen receptor antagonists (antiandrogens): Structure-activity relationships
SM Singh et al.
CURRENT MEDICINAL CHEMISTRY (2000)
分享论文
